Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. ASCENDIS PHARMA, Palo Alto, CA – FDA Inspections
Company
•United States

ASCENDIS PHARMA, Palo Alto, CA – FDA Inspections

Inspection records and compliance data for ASCENDIS PHARMA in Palo Alto, California. 1 FDA inspection on record, last inspected May 04, 2021.

Sign in to open in Dashboard
Company Profile

This profile covers ASCENDIS PHARMA based in Palo Alto, California, United States.

FDA Inspection History

FDA inspections
1
OAI
0
VAI
0
NAI
1
Form 483s
0
Warning letters
0

Inspected May 4, 2021.

FDA inspections (1)

DateResultFDA center(s)Insp. #
May 4, 2021NAIHuman Drugs · Bioresearch Monitoring1141755
FDA documents

Other FDA documents (1)

  • Other FDA documents
People (1)
Stephanie Chan, MS
Person
Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Milton Hom, OD
New Look Cosmetics, Inc.
Ardelyx, Inc.
Dante Pieramici, M.D.
Samer K. Khaled, M.D.
Elemental Herbs, Inc.
Ultra Chem Labs Corp
Jeffrey Ralph, M.D.
Flavio Vincenti, M.D.
BioCorRx Inc
Company Information

Name

ASCENDIS PHARMA

FEI Number

3015552127

Address

500 Emerson St, Palo Alto, California 94301, United States

Country

United States

ID: 68daedf3-4586-4032-82bd-f2e55fb726aa

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.